Rho-kinase inhibitors in ophthalmology
Rho-kinase (ROCK) inhibitor is the newer drug available for glaucoma in the Indian market. It seems to target the actual area of disease pathology which has not been the case with the available medications. With the ever-evolving potential of these drugs in various diseases in ophthalmology, it woul...
Сохранить в:
| Главные авторы: | , |
|---|---|
| Формат: | Artigo |
| Язык: | Inglês |
| Опубликовано: |
Wolters Kluwer Medknow Publications
2021-01-01
|
| Серии: | TNOA Journal of Ophthalmic Science and Research |
| Предметы: | |
| Online-ссылка: | http://www.tnoajosr.com/article.asp?issn=2589-4528;year=2021;volume=59;issue=1;spage=56;epage=60;aulast=Gopalakrishna |
| Метки: |
Нет меток, Требуется 1-ая метка записи!
|